Akero Therapeutics Inc (AKRO)
45.22 x 1 45.27 x 3
Post-market by (Cboe BZX)
45.24 +0.16 (+0.35%) 03/25/25 [NASDAQ]
45.22 x 1 45.27 x 3
Post-market 45.24 unch (unch) 16:27 ET
for Tue, Mar 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 340,238 | 316,065 | 310,355 | 623,854 | 234,207 |
| Marketable Securities | 402,840 | 401,182 | 449,839 | 279,811 | 315,803 |
| TOTAL | $770,380 | $746,888 | $776,010 | $911,280 | $559,962 |
| Non-Current Assets | |||||
| PPE Net | N/A | 15 | 16 | 17 | 18 |
| Investments And Advances | 54,751 | 69,824 | 88,133 | 0 | 19,283 |
| Other Non-Current Assets | 755 | 820 | 884 | 946 | 1,008 |
| TOTAL | $55,506 | $70,659 | $89,033 | $963 | $20,309 |
| Total Assets | $825,886 | $817,547 | $865,043 | $912,243 | $580,271 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,027 | 25,223 | 14,568 | 13,783 | 7,038 |
| Accrued Expenses | 30,727 | 18,068 | 16,606 | 16,476 | 12,090 |
| TOTAL | $39,754 | $43,291 | $31,174 | $30,259 | $19,128 |
| Non-Current Liabilities | |||||
| Long Term Debt | 35,491 | 35,326 | 35,123 | 34,981 | 25,018 |
| aiOther Non-Current Liabilities | 529 | 605 | 679 | 750 | 819 |
| TOTAL | $36,020 | $35,931 | $35,802 | $35,731 | $25,837 |
| Total Liabilities | $75,774 | $79,222 | $66,976 | $65,990 | $44,965 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,620 | 69,799 | 69,431 | 69,151 | 56,298 |
| Common Shares | 7 | 7 | 7 | 7 | 6 |
| Retained earnings | -826,156 | -756,132 | -683,427 | -627,440 | -574,096 |
| Other shareholders' equity | 948 | 2,103 | -261 | -79 | 270 |
| TOTAL | $750,112 | $738,325 | $798,067 | $846,253 | $535,306 |
| Total Liabilities And Equity | $825,886 | $817,547 | $865,043 | $912,243 | $580,271 |